Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma

Cairo University (CU)

Status: Active, not recruiting

Conditions: Angle Closure Glaucoma

Treatments: Procedure: phaco+MP-TSCPC; Procedure: phaco+TSCPC; Procedure: phaco+endocyclophotocoagulation; Procedure: phaco GSL

Study type: Interventional

Funder types: Other

Identifiers

NCT05576493

N-68-2022

Details and patient eligibility

About

comparing different types of cuclophotocoagulation with cataract extraction to cataract extraction and goniocynechiolysis in cases of chronic angle closure glaucoma

Full description

Evaluation of the safety of MP-TSCPC , CW-TSCPC and endoscopic cyclophotocoagulation when combined with phacoemulsification in cases with CACG Comparing the efficacy of the combined procedures in control of the IOP and the success rate versus lens extraction combined with synechiolysis

Enrollment: 88 estimated patients

Sex: All

Ages: 20 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients between 20 to 70 years

chronic angle closure glaucoma

Exclusion criteria

• Patients in acute attack of angle closure.
• Patients with previous filtering surgery or cycloablative procedure

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

88 participants in 4 patient groups

A:phaco+MP-TSCPC

Experimental group

Description:

22 patients with primary angle closure glaucoma will undergo phacoemulsification and micropulse cyclophotocoagulation

Treatment:

Procedure: phaco+MP-TSCPC

B:phaco+TSCPC

Experimental group

Description:

22 patients with primary angle closure glaucoma will undergo phaco and transscleral cyclophotocoagulation

Treatment:

Procedure: phaco+TSCPC

C:phaco+endocyclophotocoagulation

Experimental group

Description:

22 patients with primary angle closure glaucoma will undergo phaco and endocyclophotocoagulation after cataract removal

Treatment:

Procedure: phaco+endocyclophotocoagulation

D:phaco GSL

Experimental group

Description:

22 patients with primary angle closure glaucoma will undergo phaco and goniosynechiolysis

Treatment:

Procedure: phaco GSL